UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037515
Receipt number R000042422
Scientific Title DYNAMIC-FFRct study (DiscoverY of Novel Assessment Myocardical IsChemia by FFRct study)
Date of disclosure of the study information 2019/07/29
Last modified on 2022/07/31 14:45:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

DYNAMIC-FFRct study (DiscoverY of Novel Assessment Myocardical IsChemia by FFRct study)

Acronym

DYNAMIC FFRct study

Scientific Title

DYNAMIC-FFRct study (DiscoverY of Novel Assessment Myocardical IsChemia by FFRct study)

Scientific Title:Acronym

DYNAMIC FFRct study

Region

Japan


Condition

Condition

Coronary artery disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the prognosis of patients with coronary artery disease diagnosed properly using FFRCT under insurance indication in Japan

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

To assess the incidence of major coronary events (MACE) 1 year after diagnosis of patients undergoing FFRCT.
MACE is all cause of death, nonfatal myocardial infarction and emergency hospitalization of ACS

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

110 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with stable clinical symptoms diagnosed with CAD by CCTA and FFRCT indication under Japanese insurance indication.

Key exclusion criteria

1.Not CAD by CCTA
2.It was judged as unreadable due to severe artefacts.
3.Life expectancy less than 1 year
4.Inability to comply with follow-up period requirements

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Shinichiro
Middle name
Last name Fujimoto

Organization

Juntendo University Graduate School of Medicine

Division name

Cardiology

Zip code

113-8431

Address

3-1-3 Hongo, Bunkyo-ku, Tokyo

TEL

03-3813-3111

Email

snfujimo@juntendo.ac.jp


Public contact

Name of contact person

1st name Shinichiro
Middle name
Last name Fujimoto

Organization

Juntendo University Graduate School of Medicine

Division name

Cardiology

Zip code

113-8431

Address

3-1-3 Hongo, Bunkyo-ku, Tokyo

TEL

03-3813-3111

Homepage URL


Email

snfujimo@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo Clinical Research and Trial Center

Address

3-1-3 Hongo, Bunkyo-ku, Tokyo

Tel

03-3814-5672

Email

kenkyu5858@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 07 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2019 Year 07 Month 29 Day

Date of IRB

2019 Year 07 Month 26 Day

Anticipated trial start date

2019 Year 07 Month 29 Day

Last follow-up date

2022 Year 12 Month 01 Day

Date of closure to data entry

2023 Year 12 Month 31 Day

Date trial data considered complete

2023 Year 12 Month 31 Day

Date analysis concluded

2025 Year 12 Month 31 Day


Other

Other related information

Perform observational research on events that occur one year after FFRCT analysis


Management information

Registered date

2019 Year 07 Month 29 Day

Last modified on

2022 Year 07 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042422


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name